Inicio › Glioma › Nueva Jersey
Ensayos clínicos de Glioma en Nueva Jersey
11 estudios sobre Glioma buscan participantes en Nueva Jersey.
Ciudades en Nueva Jersey
Texto oficial del estudio (inglés)
A Study of Mirdametinib in People With Central Nervous System Tumors
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07539441Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
- Rutgers Cancer Institute, New Brunswick
- Atlantic Health, Summit
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07326566Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
- Rutgers Cancer Institute, New Brunswick
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07703436SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Rutgers Cancer Institute, New Brunswick
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT05303519Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.
- Cooper University HealthCare, Camden
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 9 oct 2026 · NCT07439172Glioma Developmental and HyperActive Ras Tumor (DHART) Board
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 31 ago 2026 · NCT05489783Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center, Hackensack
ReclutandoFase 1
Edades de 1 a 25 · Todos los sexos · Actualizado el 18 ago 2026 · NCT04485559A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Overlook Medical Center, Summit
ReclutandoFase 2
Edades de 8 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT05503797Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT05188508A Study of 177Lu-PSMA-617 in People With Gliomas
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 jun 2026 · NCT07223034Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
- Hackensack Meridian Health, Inc, Edison
ReclutandoFase 1/2
Hasta los 18 · Todos los sexos · Actualizado el 20 nov 2025 · NCT04299191De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.